Skip to content

Difference between Heparin and Enoxaparin on inflammatory biomarkers in the treatment of heart attack (myocardial infarction).

Comparison between Heparin and Enoxaparin on inflammatory biomarkers (IL6, hs-CRP, MPO, SAA and ferritin) in STEMI.

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12611001139965
Enrollment
30
Registered
2011-11-01
Start date
2010-09-01
Completion date
Unknown
Last updated
2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

IL6,CRP,SSA and MPO have a important role in a diagnosis and prediction of mortality in myocardial infarction(MI).some studies have mentioned the anti-inflammatory effect of heparin and enoxaparin.There is no study that is shown which drug has a better effect in decreasing inflammatory bio markers. The primary purpose of this study is to find that if enoxaparin and heparin can reduce inflammatory factors and which drug has a better effect in decreasing that bio markers?

Interventions

Arm1: STEMI patients ,Intravenous bolus Heparin(60 IU/kg followed by 1000 IU per hour continuous infusion to achieve an aPTT of 50-75 seconds,48 hours)The minimum duration of heparin therapy after MI is generally 48 hours, but it may be longer, depending on the individual clinical scenario. Arm 2: STEMI patients ,enoxaparin (1mg/kg sub cutaneous every 12 hr ,48 hours)The minimum duration of enoxaparintherapy after MI is generally 48 hours, but it may be longer, depending on the individual clinic

Arm1: STEMI patients ,Intravenous bolus Heparin(60 IU/kg followed by 1000 IU per hour continuous infusion to achieve an aPTT of 50-75 seconds,48 hours)The minimum duration of heparin therapy after MI is generally 48 hours, but it may be longer, depending on the individual clinical scenario. Arm 2: STEMI patients ,enoxaparin (1mg/kg sub cutaneous every 12 hr ,48 hours)The minimum duration of enoxaparintherapy after MI is generally 48 hours, but it may be longer, depending on the individual clinical scenario.

Sponsors

Tehran university of medical science
Lead SponsorUniversity

Study design

Allocation
Randomised controlled trial
Primary purpose
Treatment

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

age >18 patients with definite STEMI diagnosis

Exclusion criteria

1-history of AMI or CHF or AF 2-history of liver( LFT> 3ULN), kidney(Cr>2 or Cr > 25% increase in baseline),thyroid disease or malignancy 3-acute or chronic infection or autoimmune disease 4- treatment with heparin or enoxaparin before study 5-pregnancy or breastfeeding 6-treatment with anti-inflammatory drug during 3 mounths ago

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026